Cancer - Syndax Pharmaceuticals, Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT05731947

A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNDX-5613 in Patients with Colorectal Cancer and Other Solid Tumors

Drug

SNDX-5613

Condition

Patients with Colorectal Cancer and Other Solid Tumors